GIIS040-Grupo de Investigación en Hematología del HCU Lozano Blesa

Mateos M, Martinez-Lopez J, Rodriguez Otero P, Gonzalez-Calle V, Gonzalez M, Oriol A, Gutierrez N, Rios-Tamayo R, Rosinol L, Alvarez Rivas M, Bargay J, Gonzalez-Rodriguez A, Alegre A, Escalante F, Inigo Rodriguez M, de la Rubia J, Teruel A, de Arriba F, Palomera Bernal L, Hernandez M, Lopez Jimenez J, Reinoso-Segura M, Garcia Mateo A, Ocio E, Paiva B, Puig N, Cedena M, Blade J, Lahuerta J, San-Miguel J, Spanish Myeloma Grp GEM Pethema . Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. JOURNAL OF CLINICAL ONCOLOGY. 2024. 10.1200/JCO.23.02771. FI-42,1

Piñana J, López-Corral L, Martino R, Vazquez L, Pérez A, Martin-Martin G, Gago B, Sanz-Linares G, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave Rubio M, Corona M, Marcos-Corrales S, Tormo M, Hernández-Rivas J, Montoro J, Rodriguez-Fernandez A, Risco-Gálvez I, Rodríguez-Belenguer P, Hernandez-Boluda J, García-Cadenas I, Ruiz-García M, Muñoz-Bellido J, Solano C, Cedillo Á, Sureda A, Navarro D, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell  Tr . SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with  hematological disorders.. Journal of Hematology & Oncology. 2022. 10.1186/s13045-022-01275-7. FI-29,9

Rosiñol L, Oriol A, Ríos R, Blanchard M, Jarque I, Bargay J, Hernández M, Cabañas V, Carrillo-Cruz E, Sureda A, Martínez-López J, Krsnik I, González M, Casado L, Martí J, Encinas C, de Arriba F, Palomera Bernal L, Sampol A, González-Montes Y, Cabezudo E, Paiva B, Puig N, Cedena M, de la Cruz J, Mateos M, San Miguel J, Lahuerta J, Bladé J. Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.. BLOOD. 2023. 10.1182/blood.2022019531. FI-21,1

Alameda D, Goicoechea I, Vicari M, Arriazu E, Nevone A, Rodriguez S, Lasa M, Puig N, Teresa Cedena M, Alignani D, Garate S, Lara-Astiaso D, Vilas-Zornoza A, Sarvide S, Ocio E, Lecumberri R, Garcia de Coca A, Labrador J, Gonzalez M, Palomera Bernal L, Gironella M, Cabanas V, Casanova M, Oriol A, Krsnik I, Perez-Montana A, de la Rubia J, de la Puerta J, de Arriba F, Michele Fazio V, Martinez-Lopez J, Lahuerta J, Mateos M, Odero M, Prosper F, Weiner A, Amit I, Nuvolone M, San Miguel J, Paiva B. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. BLOOD. 2021. 10.1182/blood.2020009754. FI-21,1

Goicoechea I, Puig N, Cedena M, Burgos L, Cordon L, Vidriales M, Flores-Montero J, Gutierrez N, Calasanz M, Martin Ramos M, Lara-Astiaso D, Vilas-Zornoza A, Alignani D, Rodriguez I, Sarvide S, Alameda D, Jose Garces J, Rodriguez S, Fresquet V, Celay J, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Ríos Jordana R, Martin-Sanchez J, Martinez-Martinez R, Sarra J, Hernandez M, de la Rubia J, Krsnik I, Moraleda J, Palomera Bernal L, Bargay J, Angel Martinez-Climent J, Orfao A, Rosinol L, Mateos M, Lahuerta J, Blade J, San Miguel J, Paiva B, PETHEMA GEM Cooperative Grp . Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma. BLOOD. 2021. 10.1182/blood.2020006731. FI-21,1

Jimenez-Ubieto A, Paiva B, Puig N, Cedena M, Martinez-Lopez J, Oriol A, Blanchard M, Rios R, Martin J, Martinez R, Sureda A, Hernandez M, de la Rubia J, Krnisk I, Cabanas V, Palomera Bernal L, Sanchez-Pina J, Bargay J, Mateos M, Rosinol L, Blade J, San Miguel J, Lahuerta J, GEM Grp Espanol Mieloma , PETHEMA Programa Espanol Tratam . Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?. BLOOD. 2021. 10.1182/blood.2021012319. FI-21,1

Botta C, Perez C, Larrayoz M, Puig N, Cedena M, Termini R, Goicoechea I, Rodriguez S, Zabaleta A, Lopez A, Sarvide S, Blanco L, Papetti D, Nobile M, Besozzi D, Gentile M, Correale P, Siragusa S, Oriol A, González-Garcia M, Sureda A, de Arriba F, Rios Tamayo R, Moraleda J, Gironella M, Hernandez M, Bargay J, Palomera Bernal L, Pérez-Montaña A, Goldschmidt H, Avet-Loiseau H, Roccaro A, Orfao A, Martinez-Lopez J, Rosiñol L, Lahuerta J, Blade J, Mateos M, San-Miguel J, Martinez Climent J, Paiva B, Programa Para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español , iMMunocell study group . Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.. Nature Communications. 2023. 10.1038/s41467-023-41562-6. FI-14,7

Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud J, di Micco P, Rosa V, Cusidó G, Schellong S, Mellado M, Del Valle Morales M, Gavín Sebastián O, Mazzolai L, Krumholz H, Monreal M, RIETE Investigators , Prandoni P, Brenner B, Farge-Bancel D, Barba R, Bertoletti L, Tzoran I, Reis A, Bosevski M, Bounameaux H, Malý R, Verhamme P, Caprini J, Adarraga M, Agudo de Blas P, Aibar J, Amado C, Arcelus J, Ballaz A, Barbagelata C, Barrón M, Barrón-Andrés B, Blanco-Molina Á, Beddar Chaib F, Botella E, Buño-Ramilo B, Castro J, Chasco L, Criado J, de Ancos C, de Miguel J, Del Toro J, Demelo-Rodríguez P, Díaz-Brasero A, Díaz-Pedroche M, Díaz-Peromingo J, Díaz-Simón R, Domínguez I, Dubois-Silva Á, Escribano J, Espósito F, Farfán-Sedano A, Fernández-Capitán C, Fernández-Reyes J, Fidalgo Á, Font C, Francisco I, Gabara C, Galeano-Valle F, García M, García-Bragado F, García de Herreros M, García de la Garza R, García-Díaz C, Gil-Díaz A, Giménez-Suau M, Gómez-Cuervo C, Grau E, Guirado L, Gutiérrez J, Hernández-Blasco L, Jara-Palomares L, Jaras M, Jiménez D, Jiménez R, Jiménez-Alfaro C, Jou I, Joya M, Lainez-Justo S, Lalueza A, Latorre-Díez A, Lobo J, López-Jiménez L, López-Miguel P, López-Núñez J, López-Reyes R, López-Sáez J, Lorenzo A, Madridano O, Maestre A, Marchena P, Martín Del Pozo M, Martín-Martos F, Martínez-Urbistondo D, Mella C, Mercado M, Muñoz-Blanco A, Nieto J, Núñez-Fernández M, Olid-Velilla M, Otalora S, Otero R, Paredes-Ruiz D, Parra P, Parra V, Pedrajas J, Peris M, Porras J, Portillo J, Ruiz-Artacho P, Ruiz-Giménez N, Ruiz-Ruiz J, Ruiz-Sada P, Salgueiro G, Sánchez-Martínez R, Sánchez-Muñoz-Torrero J, Sancho T, Soler S, Suárez-Rodríguez B, Suriñach J, Tolosa C, Torres M, Torres-Sánchez A, Uresandi F, Valero B, Valle R, Varona J, Vázquez-Friol C, Vela L, Vela J, Villalobos A, Villares P, Zamora C, Ay C, Nopp S, Pabinger I, Engelen M, Vanassche T, Yoo H, Hirmerova J, Accassat S, Ait Abdallah N, Bura-Riviere A, Catella J, Couturaud F, Crichi B, Debourdeau P, Espitia O, Falvo N, Grange C, Helfer H, Lacut K, Le Mao R, Mahé I, Morange P, Moustafa F, Poenou G, Sarlon-Bartoli G, Suchon P, Quere I, Nikandish R, Braester A, Kenet G, Basaglia M, Bilora F, Bortoluzzi C, Brandolin B, Ciammaichella M, Corgna C, de Angelis A, Imbalzano E, Mastroiacovo D, Merla S, Pesavento R, Pomero F, Siniscalchi C, Tufano A, Visonà A, Vo Hong N, Zalunardo B, Kigitovica D, Rusa E, Skride A, Fonseca S, Martins-Duarte F, Meireles J. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated  Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE  Registry.. JAMA Cardiology. 2022. 10.1001/jamacardio.2022.1988. FI-14,7

Avendano-Sola C, Ramos-Martinez A, Munez-Rubio E, Ruiz-Antoran B, Malo de Molina R, Torres F, Fernandez-Cruz A, Calderon-Parra J, Payares-Herrera C, Diaz de Santiago A, Romera-Martinez I, Pintos I, Lora-Tamayo J, Mancheno-Losa M, Paciello M, Martinez-Gonzalez A, Vidan-Estevez J, Nunez-Orantos M, Isabel Saez-Serrano M, Porras-Leal M, Jarilla-Fernandez M, Villares P, Perez de Oteyza J, Ramos-Garrido A, Blanco L, Madrigal-Sanchez M, Rubio-Batlles M, Velasco-Iglesias A, Paño Pardo J, Moreno Chulilla J, Muniz-Diaz E, Casas-Flecha I, Perez-Olmeda M, Garcia-Perez J, Alcami J, Bueno J, Duarte R, ConPlas-19 Study Grp . A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. JOURNAL OF CLINICAL INVESTIGATION. 2021. 10.1172/JCI152740. FI-13,3

Luis Pinana J, Vazquez L, Calabuig M, Lopez-Corral L, Martin-Martin G, Villalon L, Sanz-Linares G, Conesa-Garcia V, Sanchez-Salinas A, Gago B, Facal A, Risco-Galvez I, Olave Rubio M, Espigado I, Lopez-Jimenez J, Angel Hernandez-Rivas J, Avendano-Pita A, Arroyo I, Ferrer E, Garcia-Cadenas I, Gonzalez-Santillana C, Roldan-Perez A, Ferrer B, Guerreiro M, Suarez-Lledo M, Camara A, Campos-Beltran D, Navarro D, Cedillo A, Sureda A, Solano C, Martino R, Spanish Hematopoietic Stem Cell Tr . One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Blood Cancer Journal. 2023. 10.1038/s41408-022-00778-3. FI-12,9